ATLANTA, Feb. 16, 2017 -- Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has entered into an agreement with MUCOM, L.L.C. to broker the sale or license of its patented male urinary incontinence device MUI Comfort™.
MUI Comfort™ is an integrated external collection system that meets the needs of a growing demographic that is coping with the consequences of stress, urge, and overflow incontinence. This innovative technology is differentiated from competing products by providing a complete solution that addresses both functional and psychological aspects associated with male urinary incontinence. MUI Comfort™ has several elements that are central to its patented design including:
- A lightweight collection bag with an integrated drainage neck and secured opening.
- A soft inner liner to protect the skin from perspiration and potential allergenic reaction.
- An enlarged opening with an adjustable closure mechanism that is part of three key elements that prevent accidental leaks, protect the skin, and provide secure fixation.
- A wicking component that draws urine into a superabsorbent-deodorizing polymer and will bond with any liquid to minimize odor, prevent sloshing and leakage.
- Watch the video
“We are excited to be working with the MUCOM team and representing such innovative technology that can provide millions of effected men with a superior management option for their stress, urge, and overflow incontinence,” commented Paul Gianneschi, Managing Principal at Hatch Medical L.L.C.
Donna Lou DuPree McCormack, RN, BSN, President of MUCOM, LLC commented, “We are excited to offer this innovative technology to countless men who are subjected to the embarrassment and social isolation of urinary incontinence, who have been underserved by disappointing products. Our patented technology has the potential to enhance the wellness and quality of life for untold millions of males as they eliminate the use of diapers and pads. We are delighted to be working with Hatch Medical to bring this new technology to the market.”
Founded in 2000, Hatch Medical is an incubator and broker of medical device technologies, assisting clients with development, licensing, distribution and asset sales. For information on this, or other Hatch Medical, L.L.C. products and services, email the company at [email protected]. This release and additional news about Hatch Medical can be obtained by visiting the company’s web site -- http://www.hatchmedical.com.
Contact Paul Gianneschi, Managing Principal, 770-476-9940, Steve Hvozda, Principal 949-388-9335, or Gary Robinson 215-353-0362


China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 



